Eric M Dube's Net Worth

$6.98 Million

Estimate Recalculated Nov 1, 2024 03:59AM EST

Who is Eric M Dube?

Eric M Dube has an estimated net worth of $6.98 Million. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., and Reneo Pharmaceuticals, Inc..

SEC CIK

Eric M Dube's CIK is 0001763494

Past Insider Trading and Trends

2020 was Eric M Dube's most active year for acquiring shares with 6 total transactions. Eric M Dube's most active month to acquire stocks was the month of December. 2021 was Eric M Dube's most active year for disposing of shares, totalling 10 transactions. Eric M Dube's most active month to dispose stocks was the month of December. 2019 saw Eric M Dube paying a total of $0.00 for 506,000 shares, this is the most they've acquired in one year. In 2022 Eric M Dube cashed out on 34,850 shares for a total of $984,473.34, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Travere Therapeutics, Inc. (TVTX) Snapshot price: $10.98

CHIEF EXECUTIVE OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.24%
11.38K
$11.52
-$243,360.00
361.98K
Scheduled
Sep 5 - Sep 9
Form 4
+49.37%
115.88K
$8.70
-$166,435.06
350.6K
Jan 31 - Feb 1
Form 4
-3.25%
-7.87K
$8.96
-$70,542.08
234.72K
Jan 23
Form 4
+2.30%
5.45K
$14.71
-$65,533.05
242.59K
Aug 31 - Sep 5
Form 4
+60.40%
89.3K
$22.25
-$182,361.00
237.15K
Scheduled
Jan 31 - Feb 1
Form 4
-4.18%
-6.44K
$21.50
-$138,503.00
147.85K
Scheduled
Jan 24
Form 4
-3.52%
-5.63K
$20.75
-$116,718.75
154.29K
Scheduled
Jan 5
Form 4
-2.93%
-4.83K
$27.84
-$134,522.88
159.91K
Scheduled
Feb 10
Form 4
+25.08%
33.03K
$27.40
-$131,876.20
164.75K
Scheduled
Jan 31
Form 4
-5.64%
-7.87K
$24.98
-$196,667.54
131.71K
Scheduled
Jan 24
Form 4
-11.05%
-17.33K
$30.08
-$521,406.72
139.58K
Scheduled
Jan 4 - Jan 5
Form 4
+6.56%
9.66K
$17.12
-$134,142.13
156.91K
Aug 13 - Aug 17
Form 4
-6.10%
-9.56K
$14.62
-$139,796.98
147.25K
Scheduled
Jun 1 - Jun 2
Form 4
-5.78%
-9.63K
$31.50
-$303,170.87
156.81K
Scheduled
Feb 5 - Feb 8
Form 4
+11.75%
17.5K
—
—
166.44K
Feb 3
Form 4
-1.59%
-2.41K
$28.91
-$69,557.46
148.94K
Scheduled
Feb 3
Form 4
+4.32%
6.27K
$29.91
-$261,266.72
151.34K
Scheduled
Jan 31 - Feb 2
Form 4/A
—
0
—
—
0
Jan 21
Form 4
+65.20%
57.26K
—
—
145.08K
Jan 21
Form 4
-7.26%
-6.88K
$26.83
-$184,483.08
87.82K
Scheduled
Jan 5 - Jan 6
Form 4
+22.19%
17.2K
$19.28
-$208,319.37
94.69K
Sep 18 - Sep 21
Form 4
+82.35%
35K
—
—
77.5K
Jan 31
Form 4
-15.00%
-7.50K
$14.54
-$109,050.00
42.5K
Scheduled
Jan 7 - Jan 8
Form 4
—
0
—
—
0
May 9
Form 4
∞
50K
—
—
50K
Jan 4
Form 3
—
0
—
—
0
No matching records found

Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found